Contact us  |  Disclaimer  |  Sitemap
  • ABOUT US
  • MISSION & VALUES
  • BUSINESS STRATEGY
  • OUR HISTORY
  • MANAGEMENT
  • BOARD OF DIRECTORS
  • SCIENTIFIC ADVISORY BOARDS
  • CORPORATE GOVERNANCE
    • GOVERNANCE DOCUMENTS
    • RISK MANAGEMENT
  • CAREERS
ABOUT US
  • PRODUCTS
  • LCP-Tacro™
    • Why immunosuppression?
    • About organ transplantations
    • MARKET OVERVIEW
    • Product programs
    • Development strategy and status
    • Commercial strategy
  • Cardiovascular
PRODUCTS
  • TECHNOLOGY
  • MELTDOSE® TECHNOLOGY PLATFORM
  • INTELLECTUAL PROPERTY RIGHTS
TECHNOLOGY
  • INVESTOR RELATIONS
  • RELEASES
  • DOWNLOAD CENTER
  • CALENDAR
  • FINANCIAL INFORMATION
    • OUTLOOK
  • STOCK INFORMATION
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ORDER DEPTH AND LATEST TRADES
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • General Meetings
INVESTOR
  • MEDIA
MEDIA
  • INVESTOR RELATIONS
  • RELEASES
  • DOWNLOAD CENTER
  • CALENDAR
  • FINANCIAL INFORMATION
    • OUTLOOK
  • STOCK INFORMATION
    • HISTORIC STOCK LOOKUP
    • INVESTMENT CALCULATOR
    • ORDER DEPTH AND LATEST TRADES
    • DIVIDEND HISTORY
    • ANALYST COVERAGE
  • General Meetings

General Meetings


The Annual General Meeting was held on Wednesday 17 April 2013



Annual General Meeting
PDF AGM minutes 2013 311.1 KB   Add to Briefcase
PDF Veloxis Passing of Ordinary General Meeting 331.3 KB   Add to Briefcase
PDF Convene Annual General Meeting 270.3 KB   Add to Briefcase
PDF Registration Form with Proxy and Absentee Vote  59.2 KB   Add to Briefcase
PDF Articles of Association - Draft 481.7 KB   Add to Briefcase
Generalforsamling
PDF Referat af generalforsamling 2013 311.1 KB   Add to Briefcase
PDF Veloxis forløb af ordinær generalforsamling 339.4 KB   Add to Briefcase
PDF Tilmeldingsblanket med fuldmagt og brevstemme  68.1 KB   Add to Briefcase
PDF Veloxis indkalder til ordinær generalforsamling 270.1 KB   Add to Briefcase
PDF Vedtægter - udkast 360.5 KB   Add to Briefcase


SHAREHOLDER PORTAL

ENTER VELOXIS PORTAL FOR EXISTING SHAREHOLDERS


PÅ DANSK

IN ENGLISH


FEATURED INFORMATION



Shareholder Briefcase

email alerts

download library

snapshot

mobile investor

RSS News Feeds

Print Page

Email Page

Share this on: Close window
delicious Delicious
Digg Digg
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter
What is this?

Veloxis Pharmaceuticals A/S | Bøge Allé 5, 2th | DK-2970 Hørsholm | Tel. +4570333300 | CVR-no. 26 52 77 67 | info@veloxis.com